Zai Lab Limited ADR (NASDAQ:ZLAB)’s traded shares stood at 1.66 million during the latest session, with the company’s beta value hitting 1.06. At the last check today, the stock’s price was $33.46, to imply an increase of 15.62% or $4.52 in intraday trading. The ZLAB share’s 52-week high remains $31.22, putting it 6.69% up since that peak but still an impressive 59.71% since price per share fell to its 52-week low of $13.48. The company has a valuation of $3.32B, with an average of 0.79 million shares in intraday trading volume over the past 10 days and average of 680.52K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Zai Lab Limited ADR (ZLAB), translating to a mean rating of 1.14. Of 2 analyst(s) looking at the stock, 0 analyst(s) give ZLAB a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 2 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.77.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Zai Lab Limited ADR (NASDAQ:ZLAB) trade information
After registering a 15.62% upside in the latest session, Zai Lab Limited ADR (ZLAB) has traded red over the past five days. The 5-day price performance for the stock is 26.93%, and 64.50% over 30 days. With these gigs, the year-to-date price performance is 22.43%. Short interest in Zai Lab Limited ADR (NASDAQ:ZLAB) saw shorts transact 4.86 million shares and set a 7.37 days time to cover.
The extremes give us $50 and $101 for target low and target high price respectively. As such, ZLAB has been trading -201.85% off suggested target high and -49.43% from its likely low.
Zai Lab Limited ADR (ZLAB) estimates and forecasts
Looking at statistics comparing Zai Lab Limited ADR share performance against respective industry, we note that the company has underperformed competitors. Zai Lab Limited ADR (ZLAB) shares are 112.58% up over the last 6 months, with its year-to-date growth rate lower than industry average at 15.14% against 17.50%. Revenue is forecast to shrink -8.50% this quarter before jumping 20.00% for the next one. The rating firms project that company’s revenue will grow 48.70% compared to the previous financial year.
Revenue forecast for the current quarter as set by 6 analysts is 103.48M. Meanwhile, for the current quarter, a total of 6 analyst(s) estimate revenue growth to 109.27M.Earnings reports from the last fiscal year show that sales brought in 69.23M and 65.83M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 49.50% before jumping 66.00% in the following quarter.
ZLAB Dividends
Zai Lab Limited ADR has its next earnings report out on 2024-Nov-12. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Zai Lab Limited ADR (NASDAQ:ZLAB)’s Major holders
Zai Lab Limited ADR insiders hold 2.18% of total outstanding shares, with institutional holders owning 51.03% of the shares at 52.16% float percentage. In total, 51.03% institutions holds shares in the company, led by WELLINGTON MANAGEMENT GROUP LLP. As of 2024-06-30, the company held over 7.12 million shares (or 7.3211% of shares), all amounting to roughly $123.47 million.
The next major institution holding the largest number of shares is JANUS HENDERSON GROUP PLC with 6.53 million shares, or about 6.7077% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $113.13 million.
We also have New World Fund, Inc. and Vanguard Specialized-Health Care Fund as the top two Mutual Funds with the largest holdings of the Zai Lab Limited ADR (ZLAB) shares. Going by data provided on Sep 30, 2024, New World Fund, Inc. holds roughly 3.87 shares. This is just over 3.89% of the total shares, with a market valuation of $128.22 million. Data from the same date shows that the other fund manager holds a little less at 2.81, or 2.83% of the shares, all valued at about 93.16 million.
